Switch to
| Predicate | Object |
|---|---|
| rdf:type | |
| lifeskim:mentions | |
| pubmed:issue |
3
|
| pubmed:dateCreated |
1996-12-5
|
| pubmed:abstractText |
In this pilot trial, 18 patients participated in an investigation in which the combined therapy of co-trimoxazole and roxithromycin in late Lyme borreliosis was tested. The study has been performed as a result of earlier case reports in "The Lancet" where this combination has been used successfully in order to thwart late Lyme disease. The authors show that 76% of the patients recovered completely. In 2 patients, symptoms could be resolved with i.v. penicillin and 2 did not respond to any antibiotic therapy. These results show that oral therapy of co-trimoxazole and roxithromycin in combination provides similar results as i.v. antibiotics in earlier studies.
|
| pubmed:language |
eng
|
| pubmed:journal | |
| pubmed:citationSubset |
IM
|
| pubmed:chemical | |
| pubmed:status |
MEDLINE
|
| pubmed:issn |
0303-8173
|
| pubmed:author | |
| pubmed:issnType |
Print
|
| pubmed:volume |
23
|
| pubmed:owner |
NLM
|
| pubmed:authorsComplete |
Y
|
| pubmed:pagination |
99-101
|
| pubmed:dateRevised |
2005-11-17
|
| pubmed:meshHeading |
pubmed-meshheading:8798283-Administration, Oral,
pubmed-meshheading:8798283-Dose-Response Relationship, Drug,
pubmed-meshheading:8798283-Drug Administration Schedule,
pubmed-meshheading:8798283-Drug Therapy, Combination,
pubmed-meshheading:8798283-Humans,
pubmed-meshheading:8798283-Lyme Disease,
pubmed-meshheading:8798283-Pilot Projects,
pubmed-meshheading:8798283-Roxithromycin,
pubmed-meshheading:8798283-Trimethoprim-Sulfamethoxazole Combination
|
| pubmed:year |
1996
|
| pubmed:articleTitle |
Oral treatment of late Lyme borreliosis with a combination of roxithromycin and co-trimoxazole--a pilot study on 18 patients.
|
| pubmed:affiliation |
Department of Internal Medicine, University Graz.
|
| pubmed:publicationType |
Journal Article
|